『2 Minutes with Joey - LLY Stock News』のカバーアート

2 Minutes with Joey - LLY Stock News

2 Minutes with Joey - LLY Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Eli Lilly (LLY) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • LLY Today - Jul 15: Small Dip Amid Market Gains

    LLY Today - Jul 15: Small Dip Amid Market Gains
    2026/07/15
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down what went down with Eli Lilly today. So, LLY had a bit of a rough day, slipping about 1.2%. Yeah, that one stung.

    Now, let’s talk about what happened. While the overall market was on the upswing, LLY decided to take a step back. The volume was way lower than usual, too. People weren’t really rushing to buy or sell, which is kinda telling.

    So, why the dip? Well, there wasn’t a major news bomb that dropped, but it seems like investors are just taking a breather after a pretty solid run. There was chatter about Eli Lilly's performance compared to its peers, and it looks like some folks are getting cautious. Plus, there’s a lot of buzz about its future potential. Bernstein even raised the stock price target, which usually means someone’s feeling optimistic. But today? Not so much.

    Oh, and here’s a fun fact: Eli Lilly has been a solid performer for a while now. Back in 2020, the Atlas Healthcare Fund got in at around $350. Now, it’s trading over $1,200! Wild, right?

    To wrap it up, Eli Lilly took a small dip today while the market was cruising. It's a reminder that even good stocks have their off days. Just keep an eye on the future, as there’s still a lot of potential there. Remember, this is just for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • LLY Today - Jul 14: Stock Takes a Dip

    LLY Today - Jul 14: Stock Takes a Dip
    2026/07/14
    Hey there! It’s Joey here, your friendly neighborhood investor. Let’s chat about Eli Lilly today. It was a red day for LLY, down about 2.7%. Ouch!

    So, what happened? Well, the stock got smoked, dropping over 30 bucks. Not the best news, right? The volume was pretty low, too, which usually means people are sitting on the sidelines.

    Now, why did this happen? There’s a lot of chatter in the market. Bernstein raised their price target, which is usually a good sign. They see potential for Lilly to beat expectations. But then there’s this disturbing trend in the obesity drug market that’s got some folks worried. The competition is heating up, and that’s making investors a bit nervous. It’s kinda like when you’re in a race, and suddenly, everyone else speeds up. You start to sweat a little, ya know?

    Also, some predictions out there say Lilly could still hit a much higher price down the line, like $2,090. That’s wild! But with all this back-and-forth, it’s hard to know what to think. Some say things are looking good, while others are feeling cautious. It’s a mixed bag right now.

    One thing to keep an eye on is how Lilly performs in the next earnings report. That’s always a big deal. If they can show strong sales momentum, it could change the game.

    So, that’s the scoop on Eli Lilly today. It’s a bit of a rollercoaster, but hey, that’s the stock market for you! Just remember, this is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • LLY Today - Jul 13: Analyst Upgrades Boost Sentiment

    LLY Today - Jul 13: Analyst Upgrades Boost Sentiment
    2026/07/13
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down how Eli Lilly did today. Spoiler alert: it was a bit of a green day, up just a smidge at 0.22%.

    So, what happened? Well, LLY didn’t exactly have fireworks today, but it didn’t crash and burn either. It kinda just hung around, barely moving. The trading volume was way lower than usual, which usually means people weren’t really rushing to buy or sell.

    Now, why did it move this way? A couple of things were buzzing in the news. Analysts are feeling pretty optimistic about Eli Lilly, especially with the buzz around their new weight-loss drugs and some recent data they presented at a conference. Guggenheim even raised their price target on the stock, which is usually a good sign. People are chatting about how these drugs could really change the game for investors, and that’s got some folks excited. But honestly, the stock’s not moving in wild swings like it has in the past. It seems like investors are kinda waiting to see what’s next.

    Speaking of what's next, Eli Lilly's got some new data on a drug called Kisunla that they just presented. It’s creating a bit of a stir, so keep an eye on that. It could shake things up in the near future.

    Alright, that’s the scoop for today! Eli Lilly is hanging in there, and it looks like analysts are still pretty positive. Just remember, this is all for fun and info—no financial advice here. Catch you later!
    続きを読む 一部表示
    1 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません